Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;8(1):e53587.
doi: 10.1371/journal.pone.0053587. Epub 2013 Jan 8.

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease

Collaborators, Affiliations

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease

Julien Dumurgier et al. PLoS One. 2013.

Abstract

The cerebrospinal fluid (CSF) levels of the proapoptotic kinase R (PKR) and its phosphorylated PKR (pPKR) are increased in Alzheimer's disease (AD), but whether CSF PKR concentrations are associated with cognitive decline in AD patients remain unknown. In this study, 41 consecutive patients with AD and 11 patients with amnestic mild cognitive impairment (aMCI) from our Memory Clinic were included. A lumbar puncture was performed during the following month of the clinical diagnosis and Mini-Mental State Examination (MMSE) evaluations were repeated every 6 months during a mean follow-up of 2 years. In AD patients, linear mixed models adjusted for age and sex were used to assess the cross-sectional and longitudinal associations between MMSE scores and baseline CSF levels of Aβ peptide (Aβ 1-42), Tau, phosphorylated Tau (p-Tau 181), PKR and pPKR. The mean (SD) MMSE at baseline was 20.5 (6.1) and MMSE scores declined over the follow-up (-0.12 point/month, standard error [SE] = 0.03). A lower MMSE at baseline was associated with lower levels of CSF Aβ 1-42 and p-Tau 181/Tau ratio. pPKR level was associated with longitudinal MMSE changes over the follow-up, higher pPKR levels being related with an exacerbated cognitive deterioration. Other CSF biomarkers were not associated with MMSE changes over time. In aMCI patients, mean CSF biomarker levels were not different in patients who converted to AD from those who did not convert.These results suggest that at the time of AD diagnosis, a higher level of CSF pPKR can predict a faster rate of cognitive decline.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Predicted trajectories of MMSE score according to tertiles of CSF phosphorylated PKR.
Mixed model is adjusted for age, sex, tertiles of CSF pPKR and their interactions with time in months. Solid line: lower tertile of pPKR (0–65 ODU), long-dashed sline: middle tertile of pPKR (65–100 ODU), short-dashed line : upper tertile of pPKR (>100 ODU). Cognitive decline is more pronounced in patients with high levels of CSF pPKR (short-dashed line).

References

    1. Burns A, Iliffe S (2009) Alzheimer's disease. Bmj 338: b158. - PubMed
    1. Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, et al. (2010) Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement 6: 39–53. - PubMed
    1. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5–36. - PubMed
    1. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131–144. - PubMed
    1. Tapiola T, Pirttila T, Mehta PD, Alafuzofff I, Lehtovirta M, et al. (2000) Relationship between apoE genotype and CSF beta-amyloid (1–42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol Aging 21: 735–740. - PubMed

Publication types